Letter to Members

Dan Bradbury
Chairman, 2010
BIOCOM Board of Directors
Amylin Pharmaceuticals,
President and CEO

Alex Lukianov
Chairman-Elect, 2011
BIOCOM Board of Directors
NuVasive, Chairman and CEO

"BIOCOM entered 2011
with a heightened
optimism and
continued desire to
support its members –
at every level."

Joe Panetta
BIOCOM President and CEO

BIOCOM and the Southern California life sciences community experienced growth and success in 2010, despite continuing economic pressures. BIOCOM's public policy efforts throughout the state and in Washington, D.C. eliminated barriers to innovation and business for BIOCOM's member companies. Several new initiatives were developed by BIOCOM to meet the growing and evolving needs of its members. BIOCOM also continued to support the financial health of its members through educational events and a purchasing group that provides robust savings for member companies and their employees.

Defeated 100 % of harmful state legislation
Saved members $34.5 million through the BIOCOM Purchasing Group in 2010
Facilitated meetings with government officials to award $67 million to county biotech
Produced more than 75 education/networking events a year
Regularly met with members of the CA Congressional Delegation
Arranged more than 60 member meetings with potential investor partners
Offered more than 150 local area business discounts in Employee Perks Program
Informed more than 10,000 readers through twice monthly electronic newsletter
Educated more than 5,000 top executives through quarterly LifeLines magazine